Announce Date | 05/01/2025 |
EPS Normalized Actual | $0.14 (Miss by $-0.04) |
EPS GAAP Actual | $0.14 (Miss by $-0.04) |
Revenue Actual | $1.225B |
Revenue Surprise | Beat by $1225M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.38268 |
EPS GAAP Estimate | $0.38268 |
Revenue Estimate | $1.457457862B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | 1.69177 | 10.65 | 1.66421 | 1.70738 | 1 |
Dec 2025 | 1.35394 | 13.3 | 1.26668 | 1.4412 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.28 | -0.12801 | 1.225B | 100% | -178.35M |
FQ3 2024 (Sep 2024) | -1.19 | -2.73141 | 1.25B | 100% | -1508M |
FQ2 2024 (Jun 2024) | 0.23 | 0.23 | 1.255B | 100% | 1255M |
FQ1 2024 (Mar 2024) | 0.04 | 0.04 | 1.172B | 100% | 1172M |
FQ3 2012 (Sep 2012) | -1.27 | -1.27 | 3.46B | 100% | 3460M |
FQ4 2012 (Dec 2012) | 0.4 | 0.4 | 3.454B | 100% | 3454M |
FQ1 2013 (Mar 2013) | 0 | 0 | 3.299B | 100% | 3299M |
FQ2 2013 (Jun 2013) | 0 | 0 | 3.613B | 100% | 3613M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.38268
Consensus Revenue Estimates
1.457457862B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0.54093 | -- | 0.52701 | 0.55264 | 1 |
FQ3 2026 (Jul 2026) | 0.48569 | -- | 0.4732 | 0.49621 | 1 |
FQ2 2026 (Jun 2026) | 0.48569 | -- | 0.45907 | 0.51022 | 1 |
FQ1 2026 (Mar 2026) | 0.21439 | -- | 0.20264 | 0.22522 | 1 |
FQ4 2025 (Oct 2025) | 0.43005 | 34.89 | 0.41899 | 0.43936 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 1.52B | -- | 1.49B | 1.54B | 2 |
FQ3 2026 (Jul 2026) | 1.49B | -- | 1.46B | 1.52B | 2 |
FQ2 2026 (Jun 2026) | 1.49B | -- | 1.43B | 1.55B | 2 |
FQ1 2026 (Mar 2026) | 1.33B | -- | 1.27B | 1.38B | 2 |
FQ4 2025 (Oct 2025) | 1.48B | 17.37 | 1.45B | 1.51B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
3
EPS # of in-lines
2
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.40801 | 0.28 | -0.12801 | -45.72% |
FQ3 2024 (Sep 2024) | 1.54141 | -1.19 | -2.73141 | 229.53% |
FQ2 2024 (Jun 2024) | 0.23 | 0.23 | 100% | |
FQ1 2024 (Mar 2024) | 0.04 | 0.04 | 100% | |
FQ3 2012 (Sep 2012) | -1.27 | -1.27 | 100% | |
FQ4 2012 (Dec 2012) | 0.4 | 0.4 | 100% | |
FQ1 2013 (Mar 2013) | 0 | 0 | NAN% | |
FQ2 2013 (Jun 2013) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $1.4B | $1.23B | $-178.35M | -14.56% |
FQ3 2024 (Sep 2024) | $2.76B | $1.25B | $-1508M | -120.64% |
FQ2 2024 (Jun 2024) | $0B | $1.26B | $1255M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.17B | $1172M | 100% |
FQ3 2012 (Sep 2012) | $0B | $3.46B | $3460M | 100% |
FQ4 2012 (Dec 2012) | $0B | $3.45B | $3454M | 100% |
FQ1 2013 (Mar 2013) | $0B | $3.3B | $3299M | 100% |
FQ2 2013 (Jun 2013) | $0B | $3.61B | $3613M | 100% |